Table 2 Spearman correlations of the Microbiome and parameter changes between timepoints 6 h and 24 h after Bruce intervention. Only correlations with significant p-values (< 0.05) are included.

From: Gut microbiome and blood biomarkers reveal differential responses to aerobic and anaerobic exercise in collegiate men of diverse training backgrounds

Group

Parameter

Microbiome feature

Spearman correlation

Adjusted p value

Control

Leptin [pg/ml]

PWY0-1241: ADP-l-glycero-&beta;-d-manno-heptose biosynthesis

0.95

< 0.001

LIF [pg/ml]

RIBOSYN2-PWY: flavin biosynthesis I (bacteria and plants)

0.90

0.02

IL-6 [pg/ml]

Bacteroides cellulosilyticus

− 0.88

0.03

LIF [pg/ml]

PWY-5971: palmitate biosynthesis (type II fatty acid synthase)

− 0.87

0.06

Il-10 [pg/ml]

PWY0-1241: ADP-l-glycero-&beta;-d-manno-heptose biosynthesis

− 0.83

0.10

LIF [pg/ml]

Bacteroides caccae

− 0.84

0.11

LIF [pg/ml]

Clostridiaceae bacterium

0.80

0.12

LIF [pg/ml]

BIOTIN-BIOSYNTHESIS-PWY: biotin biosynthesis I

− 0.80

0.12

LIF [pg/ml]

FASYN-ELONG-PWY: fatty acid elongation—saturated

− 0.79

0.12

LIF [pg/ml]

PWY-7664: oleate biosynthesis IV (anaerobic)

− 0.79

0.12

LIF [pg/ml]

PWY-6609: adenine and adenosine salvage III

0.83

0.12

LIF [pg/ml]

PWY-6519: 8-amino-7-oxononanoate biosynthesis I

− 0.79

0.12

LIF [pg/ml]

PWY0-862: (5Z)-dodecenoate biosynthesis I

− 0.79

0.12

LIF [pg/ml]

PWY-6282: palmitoleate biosynthesis I (from (5Z)-dodec-5-enoate)

− 0.79

0.12

Leptin [pg/ml]

Roseburia faecis

− 0.82

0.15

LIF [pg/ml]

PWY-6572: chondroitin sulfate degradation I (bacterial)

− 0.78

0.15

FSTL1 [pg/ml]

PWY0-1241: ADP-l-glycero-&beta;-d-manno-heptose biosynthesis

− 0.80

0.16

Il-10 [pg/ml]

PWY-6700: queuosine biosynthesis I (de novo)

0.80

0.17

LIF [pg/ml]

PWY-8187: L-arginine degradation XIII (reductive Stickland reaction)

− 0.76

0.18

SPARC [pg/ml]

PWY0-1241: ADP-l-glycero-&beta;-d-manno-heptose biosynthesis

− 0.80

0.18

Strength

IL-15 [pg/ml]

PWY0-1298: superpathway of pyrimidine deoxyribonucleosides degradation

− 0.95

< 0.02

IL-10 [pg/ml]

Clostridium sp AF27 2AA

0.92

0.10

IL-6 [pg/ml]

Gemmiger formicilis

0.92

0.11

Endurance

IL-15 [pg/ml]

Eubacterium rectale

− 0.95

< 0.001

TfR [pg/ml]

Blautia wexlerae

− 0.93

< 0.01

TIMP1 [pg/ml]

Bacteroides thetaiotaomicron

0.92

< 0.01

TIMP1 [pg/ml]

PWY-5188: tetrapyrrole biosynthesis I (from glutamate)

− 0.92

< 0.01

Adiponectin [pg/ml]

PWY3O-4107: NAD salvage pathway V (PNC V cycle)

− 0.92

< 0.01

Adiponectin [pg/ml]

PWY-4041: &gamma;-glutamyl cycle

− 0.90

< 0.01

TIMP1 [pg/ml]

Blautia wexlerae

− 0.90

< 0.01

Adiponectin [pg/ml]

COLANSYN-PWY: colanic acid building blocks biosynthesis

− 0.89

< 0.01

TIMP1 [pg/ml]

GLYCOGENSYNTH-PWY: glycogen biosynthesis I (from ADP-D-Glucose)

− 0.88

< 0.01

TIMP1 [pg/ml]

PWY-5030: l-histidine degradation III

0.88

< 0.01

TIMP1 [pg/ml]

HISDEG-PWY: l-histidine degradation I

0.88

< 0.01

TIMP1 [pg/ml]

Odoribacter splanchnicus

− 0.88

< 0.01

TIMP1 [pg/ml]

Bacteroides uniformis

0.84

< 0.01

TIMP1 [pg/ml]

Dorea longicatena

0.84

< 0.01

TIMP1 [pg/ml]

Lacrimispora celerecrescens

− 0.84

< 0.01

TIMP1 [pg/ml]

OANTIGEN-PWY: O-antigen building blocks biosynthesis (E. coli)

− 0.84

< 0.01

TIMP1 [pg/ml]

DAPLYSINESYN-PWY: l-lysine biosynthesis I

− 0.83

< 0.01

TIMP1 [pg/ml]

CITRULBIO-PWY: L-citrulline biosynthesis

0.83

< 0.01

TfR [pg/ml]

KETOGLUCONMET-PWY: ketogluconate metabolism

− 0.82

0.12

TfR [pg/ml]

PWY-5188: tetrapyrrole biosynthesis I (from glutamate)

− 0.88

0.12

TIMP1 [pg/ml]

PWY-7199: pyrimidine deoxyribonucleosides salvage

0.78

0.16

TIMP1 [pg/ml]

NONOXIPENT-PWY: pentose phosphate pathway (nonoxidative branch) I

− 0.78

0.16

TIMP1 [pg/ml]

Eubacterium rectale

− 0.78

0.16

TIMP1 [pg/ml]

HSERMETANA-PWY: l-methionine biosynthesis III

− 0.78

0.16

TIMP1 [pg/ml]

P441-PWY: superpathway of N-acetylneuraminate degradation

− 0.84

0.17

TIMP1 [pg/ml]

ARGSYNBSUB-PWY: l-arginine biosynthesis II (acetyl cycle)

− 0.77

0.17

TIMP1 [pg/ml]

METH-ACETATE-PWY: methanogenesis from acetate

− 0.77

0.17

TIMP1 [pg/ml]

ARGSYN-PWY: l-arginine biosynthesis I (via l-ornithine)

− 0.77

0.17

TfR [pg/ml]

PWY-5030: l-histidine degradation III

0.84

0.18

TfR [pg/ml]

Eubacterium rectale

− 0.84

0.18

TIMP1 [pg/ml]

PWY-7237: myo-, chiro- and scyllo-inositol degradation

− 0.76

0.19

TIMP1 [pg/ml]

P41-PWY: pyruvate fermentation to acetate and (S)-lactate I

− 0.76

0.19

TIMP1 [pg/ml]

PWY-6823: molybdopterin biosynthesis

− 0.76

0.19

  1. TIMP1 (tissue inhibitor of metalloproteinases), IL-5 (interleukin 5), IL-6 (interleukin 6), IL-10 (interleukin 10), IL-15 (interleukin15), LIF (leukemia inhibitory factor), SPARC (secreted protein acidic and cysteine rich), TfR (transferrin receptor). Significant correlations (p-value < 0.05) were observed across all groups. In the control group, ADP-L-glycero-β-D-manno-heptose biosynthesis was positively correlated with leptin, while Bacteroides cellulosilyticus showed negative correlations with IL-6. The strength group revealed strong associations betweenof pyrimidine deoxyribonucleosides degradation and IL-15. In the endurance group, notable correlations included Eubacterium rectale with IL-15, and Blautia wexlerae with TfR, as well as various pathways involved in NAD (Nicotinamide Adenine Dinucleotide) salvage and histidine degradation. These findings highlight the dynamic microbiome-blood marker interactions induced by the Bruce test across different exercise modalities.
  2. Significant values are in bold.